Rizatriptan benzoate
Names
[ CAS No. ]:
145202-66-0
[ Name ]:
Rizatriptan benzoate
[Synonym ]:
Rizatriptan benzoate salt
N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine monobenzoate
N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine benzoate
Rizatriptan benzoate
1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, benzoate (1:1)
N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine benzoate (1:1)
Maxalt
MK-462 (N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt
Rizatrimptan benzoate
MFCD00866224
Benzolcarbonsäure--N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamin(1:1)
N,N-diméthyl-2-[5-(1H-1,2,4-triazol-1-ylméthyl)-1H-indol-3-yl]éthanamine benzoate
Rizatriptan
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine Benzoate
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Density]:
1.21g/cm3
[ Boiling Point ]:
504.8ºC at 760mmHg
[ Melting Point ]:
178-180°C
[ Molecular Formula ]:
C22H25N5O2
[ Molecular Weight ]:
391.466
[ Flash Point ]:
259.1ºC
[ Exact Mass ]:
391.200836
[ PSA ]:
87.04000
[ LogP ]:
3.29660
[ Vapour Pressure ]:
2.58E-10mmHg at 25°C
[ Index of Refraction ]:
1.645
[ Storage condition ]:
-20°C Freezer
MSDS
Safety Information
[ Symbol ]:
GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H360
[ Precautionary Statements ]:
P201-P280-P308 + P313
[ Hazard Codes ]:
C,Xi
[ Risk Phrases ]:
R34:Causes burns.
[ Safety Phrases ]:
S26-S36/37/39-S45
[ RIDADR ]:
3259
[ HS Code ]:
2933990090
Customs
[ HS Code ]: 2933990090
[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Articles
Br. J. Clin. Pharmacol. 71(6) , 929-35, (2011)
• Off-label use in children is widespread. New medicines lack marketing authorization for paediatric use, even when they represent significant therapeutic advantages and are intended for treatment of ...
An approach for rapid development of nasal delivery of analgesics--identification of relevant features, in vitro screening and in vivo verification.Int. J. Pharm. 420(1) , 43-50, (2011)
Drug delivery via the nasal route is gaining increasing interest over the last two decades as an alternative to oral or parenteral drug administration. In the current study an approach for rapid ident...
Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.Cephalalgia 31(7) , 786-96, (2011)
The study was carried out to assess the efficacy and tolerability of rizatriptan orally disintegrating tablet (ODT) for treating acute migraine in patients who are non-responders to sumatriptan.Many m...